Open AccessA Case: Optimal Treatment of Pregnancy with Rheumatic Heart Disease
Author(s) -
Rahayu Oktaliani,
Herlam bang,
Eka D
Publication year - 2020
Publication title -
journal of gynecology research reviews and reports
Language(s) - English
Resource type - Journals
ISSN - 2634-1255
DOI - 10.47363/jgrrr/2019(2)105
Subject(s) - medicine , pregnancy , heart disease , disease , valvular heart disease , maternal death , obstetrics , intensive care medicine , cardiology , population , genetics , environmental health , biology
The number of women who have a pre-existing cardiovascular disease (CVD) or develop cardiac problems during pregnancy is increasing, and it is the leading cause of non-obstetric mortality during pregnancy. Heart disease complicates approximately 1–3% of pregnancies and is responsible for 10 to 15% of maternal mortality. The rheumatic heart disease remains the number one worldwide cause of maternal cardiac complications in pregnant. It is important that obstetric, anesthesiologists, cardiologist, remain aware of the disease, its complications and management of valvular lesions throughout the birthing process.